EPAM vs JANX · P/E 14, rev $2.81B vs rev $10.3M
EPAM Systems Inc (EPAM) versus Janux Therapeutics Inc (JANX) — a side-by-side from cached financials, not a winner call.
EPAM Systems Inc (EPAM) is a information technology services company listed on US.
Janux Therapeutics Inc (JANX) is a biotechnology company listed on US.
Latest reported EPAM revenue for 2026-06-30 was $2.81B. Net income was $185.5M. EPAM currently screens at market cap $5.10B and trailing P/E 14.0.
Latest reported JANX revenue for 2026-06-30 was $10.3M. Net income was -$22.0M. JANX currently screens at market cap $1.49B.
EPAM currently screens at market cap $5.10B and trailing P/E 14.0. JANX currently screens at market cap $1.49B.
Not investment advice. Open the EPAM and JANX stock pages for the full models.
Not investment advice.